© 2022 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
A panel of experts discusses the clinical management of diabetic macular edema and the available and upcoming treatment options.
December 16th 2021
Joseph M. Coney, MD, and Theodore Leng, MD, FACS, define diabetic macular edema and explain the typical symptoms to watch for and patient referral patterns.
Retina specialists describe how diabetic retinopathy leads to diabetic macular edema, and the pathophysiology of the condition.
December 23rd 2021
Dr Theodore Leng reviews the preferred testing options for diabetic macular edema.
A panel of experts explains how diabetic macular edema progresses over time and how to educate patients about progression prevention.
December 30th 2021
A professor of ophthalmology describes how concomitant conditions with diabetic macular edema affect the urgency of treatment regimens.
Ehsan Rahimy, MD, and Joseph M. Coney, MD, review the available treatment options for diabetic macular edema.
January 17th 2022
Theodore Leng, MD, FACS, describes the currently available anti-VEGF agents for treating diabetic macular edema and what factors to consider when choosing a therapy.
Retina experts discuss the limitations of anti-VEGF agents in treating diabetic macular edema.
Dr Joseph M. Coney reviews his personal experience using anti-VEGF agents to treat diabetic macular edema in his clinical practice.
Ehsan Rahimy, MD, and Theodore Leng, MD, FACS, discuss how to assess patient response to treatment and when to switch agents.